Article
Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Leukemia - 1 Oct 2008
Meuleman N, Stamatopoulos B, Dejeneffe M, El Housni H, Lagneaux L, Bron D
Abstract excerpt
Soluble CD23 (sCD23) levels correlate with the stage, prognosis and overall survival (OS) of patients with chronic lymphocytic leukemia (CLL). Therefore, we prospectively evaluated sCD23 doubling time (sCD23DT) as a prognostic factor for time to treatment (TTT) and OS in 56 newly diagnosed and un...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
